GlassScriptPhysician profile
Kim M Freeman
NPI 1265472237
$2,661.77
in general payments reported to CMS, 2019-2025
21 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.52 · 2022: $137 · 2023: $383 · 2024: $1,861 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,482 · Food and Beverage: $947 · Education: $77.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,481.69 |
| Food and Beverage | $947.33 |
| Education | $77.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,633.46 | 2024 | |
| Abbvie INC. | $233.62 | 2022-2025 | |
| Gynesonics, INC. | $90.07 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myriad Women'S Health, INC. | $75.57 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $71.82 | 2021-2025 | |
| Daiichi Sankyo INC. | $71.77 | 2023 | Injectafer |
| Biogen, INC. | $71.32 | 2025 | Zurzuvae |
| Organon LLC | $67.19 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $53.16 | 2023 | |
| Pfizer INC. | $49.01 | 2024-2025 | |
| Amgen INC. | $37.76 | 2022-2024 | Prolia, Evenity |
| Pacira Pharmaceuticals Incorporated | $35.31 | 2025 | Exparel |
| Sumitomo Pharma America, INC. | $32.37 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $28.97 | 2023-2024 | Veozah |
| Convatec INC. | $19.27 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.78 | 2025 | Inspire |
| Coopersurgical, INC. | $16.82 | 2023 | Mara Console |
| Baxter Healthcare | $16.20 | 2025 | Tisseel |
| Myovant Sciences INC. | $13.93 | 2022 | |
| Aspira Women'S Health INC | $13.84 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.